Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03631953
Title Combination of Alpelisib and Trametinib in Progressive Refractory Meningiomas (ALTREM)
Acronym ALTREM
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Assistance Publique Hopitaux De Marseille
Age Groups: adult | senior
Covered Countries FRA

No variant requirements are available.